Articaine Injection, Solution
Product Images NDC 51004-1010

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Articaine (NDC 51004-1010). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Novocol Pharmaceutical Of Canada, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (1.7 mL Cartridge Carton)

Principal Display Panel (1.7 mL Cartridge Carton)
Packaging label for Articaine Injection, Solution, 4% (40 mg/mL) Articaine Hydrochloride with Epinephrine 1:100,000, for submucosal administration. The label shows the brand name Articaine, manufacturer Novocol Pharmaceutical of Canada, Inc., Quala Dental Products logo, and details including 50 single-dose cartridges (1.7 mL each). It includes storage instructions and barcodes.*
FDA Label Image

Structural Formula (Articaine HCl)

Structural Formula (Articaine HCl)
Chemical structure diagram of the active ingredient articaine hydrochloride from the ARTICAINE injection, solution product.*
FDA Label Image

Structural Formula (Epinephrine Bitartrate)

Structural Formula (Epinephrine Bitartrate)
Chemical structure of Articaine Hydrochloride and Epinephrine depicted as two separate molecular diagrams showing their atomic arrangements.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.